JAK-STAT Signalling Pathway in Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Jul 24

PMID 32698360

Citations 53

Authors

Andrew J Brooks

Tracy Putoczki

Affiliations

Soon will be listed here.

Citing Articles

[High expression of apolipoprotein C1 promotes proliferation and inhibits apoptosis of papillary thyroid carcinoma cells by activating the JAK2/STAT3 signaling pathway].

Bin Y, Li Z, Zuo S, Sun S, Li M, Song J Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):359-370.

PMID: 40031980 PMC: 11875846. DOI: 10.12122/j.issn.1673-4254.2025.02.17.

Data-driven projections of candidate enhancer-activating SNPs in immune regulation.

Hoffmann M, Vaz T, Chhatrala S, Hennighausen L BMC Genomics. 2025; 26(1):197.

PMID: 40011812 PMC: 11863423. DOI: 10.1186/s12864-025-11374-7.

Comprehensive characterization of pathogenic missense CTRP6 variants and their association with cancer.

Mehboob M, Hamid A, Senthil Kumar J, Lei X BMC Cancer. 2025; 25(1):304.

PMID: 39979869 PMC: 11840981. DOI: 10.1186/s12885-025-13685-0.

Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databases.

Hoffmann M, Hennighausen L Sci Rep. 2025; 15(1):6202.

PMID: 39979591 PMC: 11842829. DOI: 10.1038/s41598-025-90788-5.

HDAC10 and its implications in Sézary syndrome pathogenesis.

Pieniawska M, Rassek K, Skwara B, Zurawek M, Ziolkowska-Suchanek I, Visser L Front Cell Dev Biol. 2025; 13:1480192.

PMID: 39958888 PMC: 11825767. DOI: 10.3389/fcell.2025.1480192.

References

Seffens A, Herrera A, Tegla C, Buus T, Hymes K, Odum N . STAT3 Dysregulation in Mature T and NK Cell Lymphomas. Cancers (Basel). 2019; 11(11). PMC: 6896161. DOI: 10.3390/cancers11111711. View

Campos L, Pissinato L, Yunes J . Deleterious and Oncogenic Mutations in the . Cancers (Basel). 2019; 11(12). PMC: 6966522. DOI: 10.3390/cancers11121952. View

Karjalainen A, Shoebridge S, Krunic M, Simonovic N, Tebb G, Macho-Maschler S . TYK2 in Tumor Immunosurveillance. Cancers (Basel). 2020; 12(1). PMC: 7017180. DOI: 10.3390/cancers12010150. View

Owen K, Brockwell N, Parker B . JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression. Cancers (Basel). 2019; 11(12). PMC: 6966445. DOI: 10.3390/cancers11122002. View

White C, Jayasekara W, Picard D, Chen J, Watkins D, Cain J . A Sexually Dimorphic Role for STAT3 in Sonic Hedgehog Medulloblastoma. Cancers (Basel). 2019; 11(11). PMC: 6895805. DOI: 10.3390/cancers11111702. View

Valle-Mendiola A, Soto-Cruz I . Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes. Cancers (Basel). 2020; 12(1). PMC: 7016889. DOI: 10.3390/cancers12010124. View

Kim J, Choi H, Kim S, Lee D . The PAK1-Stat3 Signaling Pathway Activates Gene Transcription and Human Breast Cancer Stem Cell Formation. Cancers (Basel). 2019; 11(10). PMC: 6826853. DOI: 10.3390/cancers11101527. View

Basu R, Kulkarni P, Qian Y, Walsh C, Arora P, Davis E . Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma. Cancers (Basel). 2019; 11(9). PMC: 6769493. DOI: 10.3390/cancers11091352. View

Lokau J, Schoeder V, Haybaeck J, Garbers C . Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma. Cancers (Basel). 2019; 11(11). PMC: 6896168. DOI: 10.3390/cancers11111704. View

10.

Liau N, Laktyushin A, Morris R, Sandow J, Nicola N, Kershaw N . Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1. Cancers (Basel). 2019; 11(11). PMC: 6896158. DOI: 10.3390/cancers11111701. View

11.

Saad M, Rose-John S, Jenkins B . ADAM17: An Emerging Therapeutic Target for Lung Cancer. Cancers (Basel). 2019; 11(9). PMC: 6769596. DOI: 10.3390/cancers11091218. View

12.

Moll H, Mohrherr J, Blaas L, Musteanu M, Stiedl P, Grabner B . A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. Cancers (Basel). 2019; 11(9). PMC: 6770775. DOI: 10.3390/cancers11091226. View

13.

Yun J, Lee S, Kim H, Chun S, Engleman E, Kim H . A Novel Type of Blood Biomarker: Distinct Changes of Cytokine-Induced STAT Phosphorylation in Blood T Cells Between Colorectal Cancer Patients and Healthy Individuals. Cancers (Basel). 2019; 11(8). PMC: 6721561. DOI: 10.3390/cancers11081157. View

14.

Maurer B, Kollmann S, Pickem J, Hoelbl-Kovacic A, Sexl V . STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia. Cancers (Basel). 2019; 11(11). PMC: 6895831. DOI: 10.3390/cancers11111726. View

15.

Raivola J, Haikarainen T, Silvennoinen O . Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling. Cancers (Basel). 2020; 12(1). PMC: 7016850. DOI: 10.3390/cancers12010078. View

16.

Morgan E, MacDonald A . JAK2 Inhibition Impairs Proliferation and Sensitises Cervical Cancer Cells to Cisplatin-Induced Cell Death. Cancers (Basel). 2019; 11(12). PMC: 6966458. DOI: 10.3390/cancers11121934. View

17.

Benerini Gatta L, Melocchi L, Bugatti M, Missale F, Lonardi S, Zanetti B . Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome. Cancers (Basel). 2019; 11(9). PMC: 6770563. DOI: 10.3390/cancers11091219. View

18.

Wang T, Yang J, Dighe S, Schmachtenberg M, Leigh N, Farber E . Whole Genome Sequencing of Spontaneously Occurring Rat Natural Killer Large Granular Lymphocyte Leukemia Identifies JAK1 Somatic Activating Mutation. Cancers (Basel). 2020; 12(1). PMC: 7017127. DOI: 10.3390/cancers12010126. View

19.

Severin F, Frezzato F, Visentin A, Martini V, Trimarco V, Carraro S . In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment. Cancers (Basel). 2019; 11(12). PMC: 6966457. DOI: 10.3390/cancers11121939. View

20.

Zhu F, Wang K, Rui L . STAT3 Activation and Oncogenesis in Lymphoma. Cancers (Basel). 2019; 12(1). PMC: 7016717. DOI: 10.3390/cancers12010019. View